Acta Med. 2006, 49: 167-173

https://doi.org/10.14712/18059694.2017.127

IMRT with the Use of Simultaneous Integrated Boost in Treatment of Head and Neck Cancer: Acute Toxicity Evaluation

Milan Vošmika, Karel Odrážkaa, Martin Doležela, Miloslava Vaculíkováa, Petr Kordačb, Milan Zouhara, Jiří Peteraa, Jan Jansaa, Zdeněk Zoula, Petr Paluskaa, Jan Vokurkab

aCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Oncology and Radiotherapy, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Otolaryngology, Head and Neck Surgery, Hradec Králové, Czech Republic

Received August 1, 2006
Accepted September 1, 2006

References

1. Amosson CM, Teh BS, Van TJ et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys 2003; 56:136–44. <https://doi.org/10.1016/S0360-3016(03)00093-2>
2. Baumann M, Bentzen SM, Ang KK. Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data. Radiother Oncol 1998; 46:127–130. <https://doi.org/10.1016/S0167-8140(97)00173-4>
3. Bernier J, Domenge C, Ozsahin M et al. European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350:1945–52. <https://doi.org/10.1056/NEJMoa032641>
4. Bourhis J, Amand C, Pignon JP, on behalf of the MACH-NC Collaborative Group. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. J Clin Oncol 2004; 22 (Suppl.): 5505. <https://doi.org/10.1200/jco.2004.22.14_suppl.5505>
5. Bourhis J, Syz N, Overgaard J et al. Conventional vs modified fractionated radiotherapy, meta-analysis of radiotherapy in head & neck squamous cell carcinoma: a meta-analysis based on individual patient data abstract Int J Radiat Oncol Biol Phys 2002; 54 (Suppl 1):71–72. <https://doi.org/10.1016/S0360-3016(02)03180-2>
6. Budach V, Stuschke M, Budach W et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95–06 Prospective Randomized Trial. J Clin Oncol 2005; 23:1125–35. <https://doi.org/10.1200/JCO.2005.07.010>
7. Calais G. Late toxicity in patients treated with concurrent chemotherapy and radiotherapy for head and neck cancers Radiother Oncol 2004; 73(Suppl.1): S71.
8. Chao KS, Deasy JO, Markman J et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 49:907–16. <https://doi.org/10.1016/S0360-3016(00)01441-3>
9. Cooper JS, Pajak TF, Forastiere A, et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85–03 and #88–24: targets for postoperative radiochemotherapy? Head Neck 1998; 20:588–94. <https://doi.org/10.1002/(SICI)1097-0347(199810)20:7<588::AID-HED2>3.0.CO;2-F>
10. de Kruijf WJM, Heijmen BJM,Voet P,van der Est H, Levendag PC. The importance of the low-dose part (D smaller than 95%) of the PTV-DVH in head and neck IMRT. Radiother Oncol 2004; 73 (Suppl. 1), S89.
11. Dogan N, King S, Emami B et al. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys 2003; 57:1480–91. <https://doi.org/10.1016/S0360-3016(03)01569-4>
12. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity- modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45:577–87. <https://doi.org/10.1016/S0360-3016(99)00247-3>
13. Fowler JF, Harari PM, Leborgne F, Leborgne JH. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother Oncol 2003; 69:161–168. <https://doi.org/10.1016/S0167-8140(03)00231-7>
14. Horiot JC, Bontemps P, van den Bogaert W et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44:111–21. <https://doi.org/10.1016/S0167-8140(97)00079-0>
15. Lauve A, Morris M, Schmidt-Ullrich R et al. Simultaneous integrated boost intensity- modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—clinical results. Int J Radiat Oncol Biol Phys 2004; 60: 374–87. <https://doi.org/10.1016/j.ijrobp.2004.03.010>
16. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003; 57:49–60. <https://doi.org/10.1016/S0360-3016(03)00405-X>
17. Lee N, Xia P, Quivey JM et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 53:12–22. <https://doi.org/10.1016/S0360-3016(02)02724-4>
18. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003; 57:61–70. <https://doi.org/10.1016/S0360-3016(03)00361-4>
19. Maguire PD, Meyerson MB, Neal CR et al. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA headand- neck cancer in the community. Int J Radiat Oncol Biol Phys 2004; 58: 698–704. <https://doi.org/10.1016/S0360-3016(03)01576-1>
20. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46:619–30. <https://doi.org/10.1016/S0360-3016(99)00438-1>
21. Niemierko A. A generalized concept of equivalent uniform dose (abstract). Med Phys 1999; 26:1100.
22. Overgaard J, Hansen HS, Specht L et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003; 362:933–40. <https://doi.org/10.1016/S0140-6736(03)14361-9>
23. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355:949–955. <https://doi.org/10.1016/S0140-6736(00)90011-4>
24. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000; 47:1–12. <https://doi.org/10.1016/S0360-3016(99)00558-1>
25. Sultanem K, Shu HK, Xia P et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000; 48: 711–22. <https://doi.org/10.1016/S0360-3016(00)00702-1>
26. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000; 46:195–205. <https://doi.org/10.1016/S0360-3016(99)00304-1>
27. Yao M, Dornfeld KJ, Buatti JM et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma – the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005; 63:410–421. <https://doi.org/10.1016/j.ijrobp.2005.02.025>
28. http://www.rtog.org/members/protocols/h0022/h0022.pdf.
29. http://www.rtog.org/members/protocols/0225/0225.pdf.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive